On Monday, ImmunityBio Inc (NASDAQ: IBRX) opened higher 7.69% from the last session, before settling in for the closing price of $2.47. Price fluctuations for IBRX have ranged from $1.83 to $7.48 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 2.39%. Company’s average yearly earnings per share was noted 21.18% at the time writing. With a float of $98.33 million, this company’s outstanding shares have now reached $915.63 million.
ImmunityBio Inc (IBRX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ImmunityBio Inc is 89.60%, while institutional ownership is 13.27%.
ImmunityBio Inc (IBRX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.12 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.18) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.55% during the next five years compared to 2.39% growth over the previous five years of trading.
ImmunityBio Inc (NASDAQ: IBRX) Trading Performance Indicators
Check out the current performance indicators for ImmunityBio Inc (IBRX). In the past quarter, the stock posted a quick ratio of 3.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 44.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.49, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of ImmunityBio Inc (IBRX)
Compared to the last year’s volume of 8.31 million, its volume of 9.71 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 55.86%.
During the past 100 days, ImmunityBio Inc’s (IBRX) raw stochastic average was set at 30.82%, which indicates a significant decrease from 97.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.12 in the past 14 days, which was lower than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.49, while its 200-day Moving Average is $2.74. Nevertheless, the first resistance level for the watch stands at $2.71 in the near term. At $2.77, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.86. If the price goes on to break the first support level at $2.56, it is likely to go to the next support level at $2.47. Now, if the price goes above the second support level, the third support stands at $2.41.
ImmunityBio Inc (NASDAQ: IBRX) Key Stats
There are currently 984,965K shares outstanding in the company with a market cap of 2.51 billion. Presently, the company’s annual sales total 14,750 K according to its annual income of -413,560 K. Last quarter, the company’s sales amounted to 26,430 K and its income totaled -92,560 K.
